AlphAIalphai — Financial news for AI agents
stocktitan.netAUG 271 min read$JHX

James Hardie (NYSE: JHX) exec sells shares after $11.23 options exercise

James Hardie (JHX) President Jonathan Skelly exercised 50,000 employee stock options at $11.23 per share and sold 65,000 shares at $30.45-$30.46, totaling $1.98M. The options were assumed during the AZEK Company acquisition. Skelly holds 287,721 options and 309,906 shares post-transaction.

Original reporting
stocktitan.net
Published Aug 27, 2026, 11:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 27, 2026, 12:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefFinancial news
Primary signal
$JHX
Neutral
medium confidence
Mentioned
$JHX
Relevance
5/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$JHXNeutralLow
01

Why it matters

The transaction provides fresh data on insider sentiment but is unlikely to move the stock significantly.

02

Market read

Primary insider filing; modest relevance for traders monitoring insider activity.

03

What to watch

Holding of 287,721 options suggests continued long‑term confidence.

Relevance 5/10Novelty 6/10Timing: 2026-08-25 (same‑day filing)

Background

James Hardie Industries plc (JHX) disclosed a Form 4 filing showing executive Jonathan Skelly's option exercise and share sale.

Company-level read

Ticker impact

$JHXNeutralMedium confidence
Context

President Jonathan Skelly exercised 50,000 options at $11.23 and sold 65,000 shares at ~$30.45 on 2026-08-25, generating $1.98M cash.

Expected impact

Potential short-term downward pressure, likely limited to a few cents.

Evidence & confidence

Sale size is modest for a mid-cap; insider is a senior exec, but no 10b5-1 plan, suggesting discretionary action.

Market effects

Sector

None specific; reflects typical insider activity in building products sector.

Regional

US market only; no broader regional effect.

Global

Low

Counterpoint

What could challenge this read

Insider sale could be routine liquidity event rather than a negative signal.

Key entities

  • company
    James Hardie Industries plc

    Building products manufacturer listed on NYSE.

  • person
    Jonathan Skelly

    President of James Hardie North America.

Read at source← All news

Related articles

AUG 24
$JHXHighAI 9/10

Fitch revises James Hardie outlook on European divestiture

Fitch affirmed James Hardie's 'BBB' rating and revised its outlook to Stable from Negative after the company agreed to sell its European business to Holcim for $980M. The deal, expected to close in 2027, includes the sale of Fermacell and the closure of its European fiber cement business. Fitch expects James Hardie's EBITDA leverage to decrease to 2.5x by FYE 2027, supported by debt paydown and sale proceeds. The European operations contributed 11.5% of revenue and 7.2% of EBITDA in fiscal 2026.

investing.com3 min
AUG 21
$JHXHighAI 9/10

James Hardie to sell Fermacell for €840m to Holcim

James Hardie will sell its European walling and flooring business, Fermacell, to Holcim for €840m. The company plans to close its European fibre cement business, focusing on North America. Proceeds will repay debt and fund a $250m share repurchase program. Holcim expects the deal to be earnings-accretive from 2027.

rte.ie2 min
AUG 21
$JHXHighAI 9/10

James Hardie ditches Europe, selling out to Holcim in $1.38b deal

James Hardie Industries is selling its Fermacell business in Europe to Holcim for €840 million ($1.38 billion) and exiting the region. The company will focus on its North American operations. According to James Hardie, the deal marks the end of its nine-year ownership of Fermacell.

afr.com1 min
AUG 20
$JHXHighAI 9/10

James Hardie Selling European Fermacell Business for $980 Million to Holcim

James Hardie Industries is selling its European Fermacell business to Holcim for $980 million, aiming to focus on higher-growth markets. The deal, expected to close in early 2027, will strengthen James Hardie's balance sheet and reduce debt. The company plans to use $600 million of the proceeds to repay debt and authorized a $250 million share repurchase program.

morningstar.com2 min
AUG 20
$JHXHighAI 9/10

James Hardie Industries plc: James Hardie Announces Strategic Divestiture of European Operations, Including Sale of Fermacell to Holcim for €840 Million

James Hardie (JHX) is selling its European operations, including Fermacell, to Holcim (HOLN) for €840 million. The company will also close its European fiber cement business. Proceeds will be used to repay debt and fund a $250 million share buyback program. The deal is expected to close in early 2027.

finanznachrichten.de3 min